References:
1. Hansen CL, Chaves SS, Demont C,
Viboud C. Mortality associated with influenza and respiratory syncytial
virus in the US, 1999-2018. JAMA Network Open. 2022;5(2):e220527-e.
2. Organization WH. Global Influenza
Strategy 2019-2030. 2020.
3. Thommes EW, Kruse M, Kohli M,
Sharma R, Noorduyn SG. Review of seasonal influenza in Canada: Burden of
disease and the cost-effectiveness of quadrivalent inactivated influenza
vaccines. Human vaccines & immunotherapeutics. 2017;13(4):867-76.
4. Macias AE, McElhaney JE, Chaves SS,
Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza
beyond respiratory illness. Vaccine. 2021;39:A6-A14.
5. Organization WH. Cardiovascular
diseases (CVDs) Fact sheet: World Health Organization; 2017 [Available
from: http://www.who.int/mediacentre/factsheets/fs317/en/.
6. Bowry AD, Lewey J, Dugani SB,
Choudhry NK. The burden of cardiovascular disease in low-and
middle-income countries: epidemiology and management. Canadian Journal
of Cardiology. 2015;31(9):1151-9.
7. Miranda JJ, Barrientos-Gutierrez T,
Corvalan C, Hyder AA, Lazo-Porras M, Oni T, et al. Understanding the
rise of cardiometabolic diseases in low-and middle-income countries.
Nature medicine. 2019;25(11):1667-79.
8. Arnold N, Lechner K, Waldeyer C,
Shapiro MD, Koenig W. Inflammation and cardiovascular disease: the
future. European Cardiology Review. 2021;16.
9. Stewart S, Keates AK, Redfern A,
McMurray JJ. Seasonal variations in cardiovascular disease. Nature
Reviews Cardiology. 2017;14(11):654-64.
10. Hernández EG, O’Callaghan AC,
Doménech JC, Merino VL, Mañez RS, Errazti IE, et al. Seasonal variations
in admissions for acute myocardial infarction. The PRIMVAC study.
Revista Española de Cardiología (English Edition). 2004;57(1):12-9.
11. Madjid M, Miller CC, Zarubaev VV,
Marinich IG, Kiselev OI, Lobzin YV, et al. Influenza epidemics and acute
respiratory disease activity are associated with a surge in
autopsy-confirmed coronary heart disease death: results from 8 years of
autopsies in 34 892 subjects. European heart journal.
2007;28(10):1205-10.
12. Reichert TA, Simonsen L, Sharma
A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in
mortality in the United States, 1959–1999. American journal of
epidemiology. 2004;160(5):492-502.
13. Warren-Gash C, Bhaskaran K,
Hayward A, Leung GM, Lo S-V, Wong C-M, et al. Circulating influenza
virus, climatic factors, and acute myocardial infarction: a time series
study in England and Wales and Hong Kong. Journal of Infectious
Diseases. 2011;203(12):1710-8.
14. Acosta E, Hallman SA, Dillon LY,
Ouellette N, Bourbeau R, Herring DA, et al. Determinants of influenza
mortality trends: Age-period-cohort analysis of influenza mortality in
the United States, 1959–2016. Demography. 2019;56(5):1723-46.
15. García‐Lledó A, Rodríguez‐Martín
S, Tobías A, García‐de‐Santiago E, Ordobás‐Gavín M, Ansede‐Cascudo JC,
et al. Relationship between influenza, temperature, and type 1
myocardial infarction: An ecological time‐series study. Journal of the
American Heart Association. 2021;10(8):e019608.
16. Barnes M, Heywood AE, Mahimbo A,
Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and
influenza: a meta-analysis of case–control studies. Heart.
2015;101(21):1738-47.
17. Warren-Gash C, Hayward AC,
Hemingway H, Denaxas S, Thomas SL, Timmis AD, et al. Influenza infection
and risk of acute myocardial infarction in England and Wales: a CALIBER
self-controlled case series study. Journal of Infectious Diseases.
2012:jis597.
18. Kwong JC, Schwartz KL, Campitelli
MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial
infarction after laboratory-confirmed influenza infection. New England
Journal of Medicine. 2018;378(4):345-53.
19. Warren-Gash C, Blackburn R,
Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory
infections as triggers for acute myocardial infarction and stroke: a
self-controlled case series analysis of national linked datasets from
Scotland. European Respiratory Journal. 2018;51(3).
20. Caldeira D, Rodrigues B, David C,
Costa J, Pinto FJ, Ferreira JJ. The association of influenza infection
and vaccine with myocardial infarction: systematic review and
meta-analysis of self-controlled case series. Expert review of vaccines.
2019;18(11):1211-7.
21. Harris JE, Shah PJ, Korimilli V,
Win H. Frequency of troponin elevations in patients with influenza
infection during the 2017–2018 influenza season. IJC Heart &
Vasculature. 2019;22:145-7.
22. Fröbert O, Götberg M, Erlinge D,
Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination
after myocardial infarction: a randomized, double-blind,
placebo-controlled, multicenter trial. Circulation.
2021;144(18):1476-84.
23. Ciszewski A, Bilinska ZT, Brydak
LB, Kepka C, Kruk M, Romanowska M, et al. Influenza vaccination in
secondary prevention from coronary ischaemic events in coronary artery
disease: FLUCAD study. European heart journal. 2008;29(11):1350-8.
24. Gurfinkel EP, de la Fuente RL,
Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary
syndromes and planned percutaneous coronary interventions: the FLU
Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation.
2002;105(18):2143-7.
25. Gurfinkel EP, Leon de la Fuente
R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and
planned percutaneous coronary interventions (FLUVACS) Study: One-year
follow-up. European Heart Journal. 2004;25(1):25-31.
26. Ciccacci F, Orlando S, Majid N,
Marazzi C. Epidemiological transition and double burden of diseases in
low-income countries: the case of Mozambique. The Pan African Medical
Journal. 2020;37.
27. Zaman RU, Alamgir A, Rahman M,
Azziz-Baumgartner E, Gurley ES, Sharker MAY, et al. Influenza in
outpatient ILI case-patients in national hospital-based surveillance,
Bangladesh, 2007–2008. PloS one. 2009;4(12).
28. Ahmed M, M.A. Aleem, K. Roguski,
J. Abedin, A. Islam, K.F. Alam, E.S. Gurley, M. Rahman, E.
Azziz-Baumgartner, N. Homaira, K. Sturm-Ramirez, and A.D. Iuliano.
Estimates of seasonal influenza-associated mortality in Bangladesh,
2010-12. Influenza and Other Respiratory Viruses. 2017;in press.
29. Haast B, O’Brien P. Population
Trends and Issues. Education About Asia. 2019;24(1).
30. MacIntyre CR, Heywood AE, Kovoor
P, Ridda I, Seale H, Tan T, et al. Ischaemic heart disease, influenza
and influenza vaccination: a prospective case control study. Heart.
2013;99(24):1843-8.
31. Annex A, Annex B, Annex C.
Recommendations and laboratory procedures for detection of avian
influenza A (H5N1) virus in specimens from suspected human cases.
32. MacIntyre CR, Wang Q, Seale H,
Yang P, Shi W, Gao Z, et al. A randomized clinical trial of three
options for N95 respirators and medical masks in health workers.
American journal of respiratory and critical care medicine.
2013;187(9):960-6.
33. MacIntyre CR, Seale H, Dung TC,
Hien NT, Nga PT, Chughtai AA, et al. A cluster randomised trial of cloth
masks compared with medical masks in healthcare workers. BMJ open.
2015;5(4):e006577.
34. Porter DD, Porter HG. Respiratory
viral antigens in autopsy lung tissue specimens from patients with
cancer or myocardial infarction. Clinical infectious diseases.
1999;29(2):437-40.
35. Blackburn R, Zhao H, Pebody R,
Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as
predictors of hospital admission for myocardial infarction and stroke:
time-series analysis of English data for 2004–2015. Clinical Infectious
Diseases. 2018;67(1):8-17.
36. Ohland J, Warren-Gash C,
Blackburn R, Mølbak K, Valentiner-Branth P, Nielsen J, et al. Acute
myocardial infarctions and stroke triggered by laboratory-confirmed
respiratory infections in Denmark, 2010 to 2016. Eurosurveillance.
2020;25(17):1900199.
37. Organization WH. World Health
Organization; [Available from: https://www.who.int/tools/flunet.
38. Warren-Gash C, Geretti AM,
Hamilton G, Rakhit RD, Smeeth L, Hayward AC. Influenza-like illness in
acute myocardial infarction patients during the winter wave of the
influenza A H1N1 pandemic in London: a case–control study. BMJ open.
2013;3(5):e002604.
39. Clayton TC, Thompson M, Meade TW.
Recent respiratory infection and risk of cardiovascular disease:
case-control study through a general practice database. European heart
journal. 2008;29(1):96-103.
40. Corrales-Medina VF, Alvarez KN,
Weissfeld LA, Angus DC, Chirinos JA, Chang C-CH, et al. Association
between hospitalization for pneumonia and subsequent risk of
cardiovascular disease. Jama. 2015;313(3):264-74.
41. Guan X, Yang W, Sun X, Wang L, Ma
B, Li H, et al. Association of influenza virus infection and
inflammatory cytokines with acute myocardial infarction. Inflammation
research. 2012;61(6):591-8.
42. Organization WH. Global
epidemiological surveillance standards for influenza. 2014. 2017.
43. Chughtai AA, Tan TC, Hitchen EM,
Kunasekaran M, MacIntyre CR. Association of influenza infection and
vaccination with cardiac biomarkers and left ventricular ejection
fraction in patients with acute myocardial infarction. IJC Heart &
Vasculature. 2020;31:100648.
44. Wolf YI, Nikolskaya A, Cherry JL,
Viboud C, Koonin E, Lipman DJ. Projection of seasonal influenza severity
from sequence and serological data. PLoS currents. 2010;2.
45. Muscente F, De Caterina R. Causal
relationship between influenza infection and risk of acute myocardial
infarction: pathophysiological hypothesis and clinical implications.
European Heart Journal Supplements. 2020;22(Supplement_E):E68-E72.
46. Liberale L, Badimon L, Montecucco
F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and
cardiovascular disease: JACC review topic of the week. Journal of the
American College of Cardiology. 2022;79(8):837-47.
47. Baccarelli A, Benjamin EJ.
Triggers of Myocardial Infarction for the Individual and in the
Community. Lancet. 2011;377(9767):694.
48. Kloner RA. Natural and unnatural
triggers of myocardial infarction. Progress in cardiovascular diseases.
2006;48(4):285-300.
49. Mohammad MA, Tham J, Koul S,
Rylance R, Bergh C, Erlinge D, et al. Association of acute myocardial
infarction with influenza: A nationwide observational study. PloS one.
2020;15(8):e0236866.
50. Lechner I, Reindl M, Metzler B,
Reinstadler SJ. Predictors of Long-Term Outcome in STEMI and
NSTEMI—Insights from J-MINUET. MDPI; 2020. p. 3166.
51. Hallén J. Troponin for the
estimation of infarct size: what have we learned? Cardiology.
2012;121(3):204-12.
52. Steen H, Giannitsis E, Futterer
S, Merten C, Juenger C, Katus HA. Cardiac troponin T at 96 hours after
acute myocardial infarction correlates with infarct size and cardiac
function. Journal of the American College of Cardiology.
2006;48(11):2192-4.
53. Adak A, Devi A, Gupta PK.
Influence of Pro-and Anti-inflammatory Cytokines during Pathogenesis
Atherosclerosis: A Dynamical Approach. 2022.
54. Veizades S, Tso A, Nguyen PK.
Infection, inflammation and thrombosis: A review of potential mechanisms
mediating arterial thrombosis associated with influenza and severe acute
respiratory syndrome coronavirus 2. Biological Chemistry.
2022;403(2):231-41.
55. Carty CL, Heagerty P, Nakayama K,
McClung EC, Lewis J, Lum D, et al. Inflammatory response after influenza
vaccination in men with and without carotid artery disease.
Arteriosclerosis, thrombosis, and vascular biology. 2006;26(12):2738-44.
56. MacIntyre CR, Mahimbo A, Moa AM,
Barnes M. Influenza vaccine as a coronary intervention for prevention of
myocardial infarction. Heart. 2016;102(24):1953-6.
57. Gurfinkel EP, de la Fuente RL,
Mendiz O, Mautner B, Group FS. Influenza vaccine pilot study in acute
coronary syndromes and planned percutaneous coronary interventions the
FLU vaccination acute coronary syndromes (FLUVACS) study. Circulation.
2002;105(18):2143-7.
58. Gurfinkel E, de la Fuente RL,
Beck E, Mendiz O, Toledo D, Arechavala L, et al. 2493 Flu vaccination in
acute coronary syndromes and planned percutaneous coronary interventions
(FLUVACS) study: 1-year follow-up. European Heart Journal.
2003;5(24):469.
59. Bermúdez-Fajardo A, Oviedo-Orta
E. Influenza vaccination promotes stable atherosclerotic plaques in apoE
knockout mice. Atherosclerosis. 2011;217(1):97-105.
60. Atoui R, Ebrahim F, Saroka K,
Mireau J, McElhaney JE, Hare GM. Influenza vaccination blunts the
inflammatory response in patients undergoing cardiopulmonary bypass. The
Annals of Thoracic Surgery. 2021;111(6):1923-30.